Paper24360720
Non-invasive optical imaging of cathepsin B with activatable fluorogenic nanoprobes in various metastatic models.
Ryu JH and 14 others. Biomaterials, 2014. Cited by 40 papers, by iCite.
Cite this record
ConductScience Library. Non-invasive optical imaging of cathepsin B with activatable fluorogenic nanoprobes in various metastatic models. Papers, record 24360720. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/24360720
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Non-invasive optical imaging of cathepsin B with activatable fluorogenic nanoprobes in various metastatic models.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cathepsin B | Major topic |
| Fluorescent Dyes | Major topic |
| Models, Biological | Major topic |
| Nanostructures | Major topic |
| Neoplasm Metastasis | Major topic |
| Optical Imaging | Major topic |
| Cell Line, Tumor | |
| Chitosan | |
| Colonic Neoplasms | |
| Humans |
Source PubMed
Cited by21
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 40 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42198268 | Emerging Near-Infrared Targeted Imaging Pharmaceutics for Ovarian Cancer. | Pharmaceutics | 2026 | https://conductscience.org/library/papers/42198268 | PubMed |
| 39630111 | Profiling Pro-Inflammatory Proteases as Biomolecular Signatures of Material-Induced Subcutaneous Host Response in Immuno-Competent Mice. | Adv Sci (Weinh) | 2025 | https://conductscience.org/library/papers/39630111 | PubMed |
| 38231996 | Recent Advances in Micro- and Nano-Drug Delivery Systems Based on Natural and Synthetic Biomaterials. | Polymers (Basel) | 2023 | https://conductscience.org/library/papers/38231996 | PubMed |
| 36678755 | Study of Cytotoxicity and Internalization of Redox-Responsive Iron Oxide Nanoparticles on PC-3 and 4T1 Cancer Cell Lines. | Pharmaceutics | 2022 | https://conductscience.org/library/papers/36678755 | PubMed |
| 36421141 | Biomedical Applications of Microfluidic Devices: A Review. | Biosensors (Basel) | 2022 | https://conductscience.org/library/papers/36421141 | PubMed |
| 36254978 | The critical role of the endolysosomal system in cerebral ischemia. | Neural Regen Res | 2023 | https://conductscience.org/library/papers/36254978 | PubMed |
| 35154500 | Activated molecular probes for enzyme recognition and detection. | Theranostics | 2022 | https://conductscience.org/library/papers/35154500 | PubMed |
| 34288999 | Molecular probes for selective detection of cysteine cathepsins. | Org Biomol Chem | 2021 | https://conductscience.org/library/papers/34288999 | PubMed |
| 34093104 | Interactions Between Tumor Biology and Targeted Nanoplatforms for Imaging Applications. | Adv Funct Mater | 2020 | https://conductscience.org/library/papers/34093104 | PubMed |
| 33643830 | Cathepsin B-responsive and gadolinium-labeled branched glycopolymer-PTX conjugate-derived nanotheranostics for cancer treatment. | Acta Pharm Sin B | 2021 | https://conductscience.org/library/papers/33643830 | PubMed |
| 32635231 | Tumor-Targeting Glycol Chitosan Nanoparticles for Image-Guided Surgery of Rabbit Orthotopic VX2 Lung Cancer. | Pharmaceutics | 2020 | https://conductscience.org/library/papers/32635231 | PubMed |
| 30231877 | Nano based drug delivery systems: recent developments and future prospects. | J Nanobiotechnology | 2018 | https://conductscience.org/library/papers/30231877 | PubMed |
| 29275475 | Imaging the Tumor Microenvironment. | Adv Exp Med Biol | 2017 | https://conductscience.org/library/papers/29275475 | PubMed |
| 29022237 | Dysfunction of Membrane Trafficking Leads to Ischemia-Reperfusion Injury After Transient Cerebral Ischemia. | Transl Stroke Res | 2018 | https://conductscience.org/library/papers/29022237 | PubMed |
| 28959053 | Synergistic effect of a drug loaded electrospun patch and systemic chemotherapy in pancreatic cancer xenograft. | Sci Rep | 2017 | https://conductscience.org/library/papers/28959053 | PubMed |
| 28643153 | A 3E8.scFv.Cys-IR800 Conjugate Targeting TAG-72 in an Orthotopic Colorectal Cancer Model. | Mol Imaging Biol | 2018 | https://conductscience.org/library/papers/28643153 | PubMed |
| 28524865 | Dual-stimuli responsive and reversibly activatable theranostic nanoprobe for precision tumor-targeting and fluorescence-guided photothermal therapy. | Nat Commun | 2017 | https://conductscience.org/library/papers/28524865 | PubMed |
| 28506745 | Applying nanomedicine in maladaptive inflammation and angiogenesis. | Adv Drug Deliv Rev | 2017 | https://conductscience.org/library/papers/28506745 | PubMed |
| 27465386 | Nanoparticle-based probes to enable noninvasive imaging of proteolytic activity for cancer diagnosis. | Nanomedicine (Lond) | 2016 | https://conductscience.org/library/papers/27465386 | PubMed |
| 26157794 | Cysteine cathepsins: their role in tumor progression and recent trends in the development of imaging probes. | Front Chem | 2015 | https://conductscience.org/library/papers/26157794 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CTSB | 1508 | PubTator's text mining | https://conductscience.org/library/genes/1508 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/24360720
GET https://conductscience.org/api/papers/v1/24360720/cited_by?page=2